Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

11 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Treatment duration of febrile urinary tract infection: a pragmatic randomized, double-blind, placebo-controlled non-inferiority trial in men and women.
van Nieuwkoop C, van der Starre WE, Stalenhoef JE, van Aartrijk AM, van der Reijden TJ, Vollaard AM, Delfos NM, van 't Wout JW, Blom JW, Spelt IC, Leyten EM, Koster T, Ablij HC, van der Beek MT, Knol MJ, van Dissel JT. van Nieuwkoop C, et al. Among authors: van der starre we. BMC Med. 2017 Apr 3;15(1):70. doi: 10.1186/s12916-017-0835-3. BMC Med. 2017. PMID: 28366170 Free PMC article. Clinical Trial.
Procalcitonin, mid-regional proadrenomedullin and C-reactive protein in predicting treatment outcome in community-acquired febrile urinary tract infection.
Stalenhoef JE, van Nieuwkoop C, Wilson DC, van der Starre WE, van der Reijden TJK, Delfos NM, Leyten EMS, Koster T, Ablij HC, van 't Wout JJW, van Dissel JT. Stalenhoef JE, et al. Among authors: van der starre we. BMC Infect Dis. 2019 Feb 14;19(1):161. doi: 10.1186/s12879-019-3789-6. BMC Infect Dis. 2019. PMID: 30764769 Free PMC article. Clinical Trial.
Prognostic value of pro-adrenomedullin, procalcitonin and C-reactive protein in predicting outcome of febrile urinary tract infection.
van der Starre WE, Zunder SM, Vollaard AM, van Nieuwkoop C, Stalenhoef JE, Delfos NM, Van't Wout JW, Spelt IC, Blom JW, Leyten EM, Koster T, Ablij HC, van Dissel JT. van der Starre WE, et al. Clin Microbiol Infect. 2014 Oct;20(10):1048-54. doi: 10.1111/1469-0691.12645. Clin Microbiol Infect. 2014. PMID: 25039648 Free article.
Hospitalization for community-acquired febrile urinary tract infection: validation and impact assessment of a clinical prediction rule.
Stalenhoef JE, van der Starre WE, Vollaard AM, Steyerberg EW, Delfos NM, Leyten EMS, Koster T, Ablij HC, Van't Wout JW, van Dissel JT, van Nieuwkoop C. Stalenhoef JE, et al. Among authors: van der starre we. BMC Infect Dis. 2017 Jun 6;17(1):400. doi: 10.1186/s12879-017-2509-3. BMC Infect Dis. 2017. PMID: 28587665 Free PMC article. Clinical Trial.
Treatment duration of febrile urinary tract infections.
van der Starre WE, van Dissel JT, van Nieuwkoop C. van der Starre WE, et al. Curr Infect Dis Rep. 2011 Dec;13(6):571-8. doi: 10.1007/s11908-011-0211-y. Curr Infect Dis Rep. 2011. PMID: 21882085 Free PMC article.
Diabetes and the course of febrile urinary tract infection.
van der Starre WE, Borgdorff H, Vollaard AM, Delfos NM, van 't Wout JW, Spelt IC, Blom JW, Leyten EM, Koster T, Ablij HC, van Dissel JT, van Nieuwkoop C. van der Starre WE, et al. Diabetes Care. 2013 Dec;36(12):e193-4. doi: 10.2337/dc13-0903. Diabetes Care. 2013. PMID: 24265368 Free PMC article. No abstract available.
Urinary proteins, vitamin D and genetic polymorphisms as risk factors for febrile urinary tract infection and relation with bacteremia: a case control study.
van der Starre WE, van Nieuwkoop C, Thomson U, Zijderveld-Voshart MS, Koopman JP, van der Reijden TJ, van Dissel JT, van de Vosse E. van der Starre WE, et al. PLoS One. 2015 Mar 25;10(3):e0121302. doi: 10.1371/journal.pone.0121302. eCollection 2015. PLoS One. 2015. PMID: 25807366 Free PMC article.
11 results